These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 20886403)

  • 21. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
    Cha SW; Leung WD; Lehman GA; Watkins JL; McHenry L; Fogel EL; Sherman S
    Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
    Choksi NS; Fogel EL; Cote GA; Romagnuolo J; Elta GH; Scheiman JM; Chak A; Mosler P; Higgins PD; Korsnes SJ; Schmidt SE; Sherman S; Lehman GA; Elmunzer BJ;
    Gastrointest Endosc; 2015 Jan; 81(1):150-5. PubMed ID: 25527053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC; Pradermchai K; Avula H; Sherman S; Fogel EL; Lehman GA
    Can J Gastroenterol; 2011 Apr; 25(4):215-9. PubMed ID: 21523263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study.
    Zhang C; Yang YL; Ma YF; Zhang HW; Li JY; Lin MJ; Shi LJ; Qi CC
    BMC Gastroenterol; 2017 Oct; 17(1):108. PubMed ID: 29047328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin Does Not Reduce Post-ERCP Pancreatitis in High-Risk Patients Receiving Pancreatic Stenting.
    Bai B; Wang S; Du Y; Li M; Huang Q; Liu S; Zhang C; Fang Y; Chen X; Hong J; Li Y; Xu Z; Liu X; Hong R; Bao J; Mei Q
    Dig Dis Sci; 2024 Sep; 69(9):3442-3449. PubMed ID: 39009916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-Fr pancreatic plastic stents placed with common-type guidewires: Results from a prospective multinational registry.
    Sahar N; Ross A; Lakhtakia S; Coté GA; Neuhaus H; Bruno MJ; Haluszka O; Kozarek R; Ramchandani M; Beyna T; Poley JW; Maranki J; Freeman M; Kedia P; Tarnasky P;
    Dig Endosc; 2019 May; 31(3):299-306. PubMed ID: 30506606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.
    Singh P; Das A; Isenberg G; Wong RC; Sivak MV; Agrawal D; Chak A
    Gastrointest Endosc; 2004 Oct; 60(4):544-50. PubMed ID: 15472676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
    Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
    Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Sun HL; Han B; Zhai HP; Cheng XH; Ma K
    Surgeon; 2014 Jun; 12(3):141-7. PubMed ID: 24332479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis.
    Li S; Cao G; Chen X; Wu T
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):477-81. PubMed ID: 22293331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
    Wan J; Ren Y; Zhu Z; Xia L; Lu N
    BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis.
    Zeng C; Zhang Y; Yang H; Hong J
    Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):141-154. PubMed ID: 35020545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
    Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis.
    Tse F; Yuan Y; Moayyedi P; Leontiadis GI; Barkun AN
    Endoscopy; 2017 Jan; 49(1):15-26. PubMed ID: 27997966
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors of post-ERCP pancreatitis in high-risk patients despite prevention with prophylactic pancreatic stents.
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Scand J Gastroenterol; 2020 Jan; 55(1):95-99. PubMed ID: 31852319
    [No Abstract]   [Full Text] [Related]  

  • 39. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Elmunzer BJ
    Dig Endosc; 2017 Nov; 29(7):749-757. PubMed ID: 28636774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.